Medicus Pharma (MDCX) Accumulated Expenses (2023 - 2025)

Medicus Pharma (MDCX) has reported Accumulated Expenses for 3 consecutive years, with $995290.0 the latest figure, recorded in Q4 2025.

• Accumulated Expenses for Q4 2025 came in at $995290.0, up 30.47% year-over-year; the trailing twelve-month figure through Dec 2025 was $995290.0 (up 30.47% YoY), and the FY2025 annual result was $995290.0, up 30.47% from the prior year.
• Accumulated Expenses was $995290.0 for Q4 2025 at Medicus Pharma, down from $1.6 million in the prior quarter.
• Over five years, Accumulated Expenses peaked at $1.8 million in Q2 2025 and troughed at $404817.0 in Q4 2023.
• Average Accumulated Expenses over 3 years is $1.1 million, with a median of $1.0 million recorded in 2025.
• Year-over-year, Accumulated Expenses jumped 88.44% in 2024 and surged 30.47% in 2025.
• Over 3 years, Accumulated Expenses stood at $404817.0 in 2023, then jumped by 88.44% to $762835.0 in 2024, then soared by 30.47% to $995290.0 in 2025.
• Per Business Quant data, the three most recent Accumulated Expenses figures were $995290.0 in Q4 2025, $1.6 million in Q3 2025, and $1.8 million in Q2 2025.